Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study
Patient Education and Counseling · 2025
DOI: 10.1016/j.pec.2025.109289 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Patient Education and Counseling, 2025. Verfasst von Joaquín Gavilá und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Valenciano de Oncología, Oncology Department, Valencia, Spain. Electronic address: jogagre@hotmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Communication, Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Daiichi-Sankyo, AstraZeneca Pharmaceutical Spain.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Valenciano de Oncología, Oncology Department, Valencia, Spain. Electronic address: jogagre@hotmail.com.
- Elche General University Hospital, Oncology Department, Elche, Alicante, Spain. Electronic address: onkopinha@gmail.com.
- University Hospital Complex A Coruña (CHUAC), Oncology Department, A Coruña, Spain. Electronic address: silvia.antolin.novoa@sergas.es.
- Puerta de Hierro-Majadahonda University Hospital, Oncology Department, Madrid, Spain. Electronic address: blanca.cantos@salud.madrid.org.
- Parc Taulí University Hospital, Oncology Department, Sabadell, Barcelona, Spain. Electronic address: msegui@tauli.cat.
- Spanish Federation of Breast Cancer (FECMA), Madrid, Spain. Electronic address: tonygimon@gmail.com.
Förderung
- Daiichi-Sankyo
- AstraZeneca Pharmaceutical Spain
Zitieren
APA
Gavilá, J., Rodríguez-Lescure, Á., Antolín, S., Cantos, B., Ángel Seguí, M., Antonia Gimón, M., Rubio Renau, R., Solà Marsiñach, C., Martín Illán, J., Vallejo, R. F., Guadalupe, Y. G., Alfaro Oliver, N., & García-Sáenz, J. Á. (2025). Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study. Patient Education and Counseling. https://doi.org/10.1016/j.pec.2025.109289
Vancouver
Gavilá J, Rodríguez-Lescure Á, Antolín S, Cantos B, Ángel Seguí M, Antonia Gimón M, et al. Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study. Patient Education and Counseling. 2025. doi:10.1016/j.pec.2025.109289
BibTeX
@article{Gavil2025,
author = {Gavilá, Joaquín and Rodríguez-Lescure, Álvaro and Antolín, Silvia and Cantos, Blanca and Ángel Seguí, Miguel and Antonia Gimón, María and Rubio Renau, Raül and Solà Marsiñach, Carlota and Martín Illán, Jesús and Vallejo, Rocío Fonseca and Guadalupe, Yaiza Gimeno and Alfaro Oliver, Noelia and García-Sáenz, José Ángel},
title = {Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study},
journal = {Patient Education and Counseling},
year = {2025},
doi = {10.1016/j.pec.2025.109289}
}
EUVIMED